Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Product/R&D News
2/10/2025
NMPA Approves Sinocelltech's Anti-PD-1 Antibody Finotonlimab
2/10/2025
Sunshine Lake Pharma's NS5A Inhibitor Netanasvir Phosphate Approved in...
2/7/2025
Toll Biotech Secures FDA and NMPA IND Approvals for TLR8 Modulator Tol...
2/7/2025
Henlius Biotech's Lung Cancer Drug Secures EU Approval
2/5/2025
MediLink's YL217 received FDA Clearance of IND Application
2/2/2025
FDA Approves Minwei Biotech's IND for MWN105
2/2/2025
BeiGene Launches Phase 1 Trial for CLDN6/CD3 BsAb BGB-B455 in Solid Tu...
2/2/2025
FDA Approves XellSmart's IND for iPSC-Derived Cell Therapy in Parkinso...
1/28/2025
Akeso's Gumokimab Advances Toward Approval in China for Plaque Psorias...
1/28/2025
Chinese Researchers Develop Promising Nanovaccine for Breast Cancer Tr...
1/22/2025
Innovent Advances PD-1/IL-2α-Bias Bispecific Antibody IBI363 into Pha...
1/22/2025
YolTech to Initiate a Clinical Trial of FIC Bone Marrow-Targeted In V...
1/21/2025
NiKang Does First Patient in a Phase 1b/2 Study of NKT2152 in Combo fo...
1/21/2025
CARsgen's Allogeneic CD38 CAR-T Therapy Administers First Dose in Inve...
1/21/2025
Zai Lab's NDA for Schizophrenia Treatment KarXT Accepted in China
1/21/2025
NMPA Approves Two Homegrown Oncology Therapies for Lung and Ovarian Ca...
1/20/2025
NMPA Expands Label for Genrix Bio's Xeligekimab in Radiographic AS
1/20/2025
NMPA Expands Label for Kelun-Biotech's Tagitanlimab in First-Line NPC ...
1/17/2025
Daiichi Sankyo Submits NDA for Pexidartinib (PLX3397) in China as the ...
1/16/2025
Alphamab Advances Oncology Pipeline with Phase 2 Trial of TROP-2/HER3 ...
1/15/2025
Luye Pharma Advances CNS Pipeline with Phase II Trial for LY03015 in C...
1/15/2025
Ucello Wins FDA IND Approval for Pioneering Allogeneic CAR-T Therapy
1/14/2025
ImmuneOnco Begins Trial of Instil's NSCLC Drug in China
1/13/2025
CirCode Receives NMPA IND Approval for HM2002 Injection
1/13/2025
Akeso Launches Phase 3 Trial for Ivonescimab (AK112)
1/13/2025
Regor Releases Phase 2a Topline Results for GLP-1 RGT-075
1/13/2025
J&J's Balversa (Erdafitinib) Gains NMPA Approval for Advanced Urotheli...
1/13/2025
Hengruiand Kailera Report Positive Data from Phase 2 Obesity Trial of ...
1/12/2025
WuXi Biologics Announces Agreement with Candid Therapeutics on Trispec...
1/11/2025
Sanofi's Sarclisa (Isatuximab) Approved in China, Pioneering Use of Re...
Page:
9
/
15
Total number of articles:
433
:
[First]
[<<]
[7]
[8]
[9]
[10]
[11]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit